Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biogen Inc. (BIIB) had Revenue of $2.28B for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$2.28B
Net Income	$-48.90M
Cost of Goods Sold	$495.50M
Gross Profit	$1.78B
Operating Expenses	$2.18B
Operating Income	$98.40M
Non-Operating Income/Expense	$-154.40M
Pre-Tax Income	$-56.00M
Normalized Pre-Tax Income	$-56.00M
Income after Taxes	$-48.90M
Income from Continuous Operations	$-48.90M
Consolidated Net Income/Loss	$-48.90M
Normalized Income after Taxes	$-48.90M
EBIT	$98.40M
EBITDA	$423.40M
Weighted-Average Shares Outstanding (Basic)	146.50M
Weighted-Average Shares Outstanding (Diluted)	147.10M
Earnings per Share (EPS) (Basic)	$-0.33
Earnings per Share (EPS) (Diluted)	$-0.35
Balance Sheet Financials
Current Assets	$8.97B
Property, Plant, and Equipment	$3.06B
Long-Term Assets	$20.47B
Total Assets	$29.44B
Current Liabilities	$3.35B
Long-Term Debt	$6.29B
Long-Term Liabilities	$7.83B
Total Liabilities	$11.18B
Common Equity	$18.26B
Tangible Shareholders Equity	$2.59B
Shareholders Equity	$18.26B
Common Shares Outstanding	146.70M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.20B
Cash Flow from Investing Activities	$-1.37B
Cash Flow from Financial Activities	$-301.90M
Beginning Cash	$2.38B
End Cash	$3.01B
Increase/Decrease in Cash	$633.50M
Stock-Based Compensation	$290.80M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.68
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	0.34
Gross Margin	78.26%
Operating Margin	4.32%
EBIT Margin	4.32%
EBITDA Margin	--
Pre-Tax Profit Margin	-2.46%
Profit Margin	-2.15%
Free Cash Flow	$2.05B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	0.23
Receiveable Turnover	1.70
Days Sales in Receivables	53.00
Return on Equity	-0.27%
Return on Tangible Equity	-1.89%
Return on Assets	-0.17%
Return on Investments	-0.20%
Book Value Per Share	$124.45
Free Cash Flow per Share	$13.94
Operating Cash Flow per Share	$14.99

Data from Zacks Investment Research, Inc.